Corpus Intelligence IC Memo — VERDE VALLEY MEDICAL CENTER 2026-04-26 04:03 UTC
IC Memo — VERDE VALLEY MEDICAL CENTER
Investment Committee Memorandum | AZ | 87 beds | Grade C | EBITDA uplift $12.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

VERDE VALLEY MEDICAL CENTER

CCN 030007 | YAVAPAI, AZ | 87 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

VERDE VALLEY MEDICAL CENTER is a 87-bed suburban community hospital in YAVAPAI, AZ with $172.5M in net patient revenue and a 4.3% operating margin. The hospital serves a payer mix of 33.0% Medicare, 19.6% Medicaid, and 47.3% commercial.

Thesis: Turnaround. Our ML models identify $12.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 4.3% to 11.7% (+736bps).

Net Revenue HCRIS$172.5M
Current EBITDA COMPUTED$7.5M
Operating Margin COMPUTED4.3%
Occupancy HCRIS50.1%
Revenue / Bed COMPUTED$2.0M
Net-to-Gross HCRIS26.1%
Distress Probability ML50.6%

2. Market Context & Competitive Position

124
AZ Hospitals
-0.8%
State Median Margin
56
Comparable Hospitals

AZ has 124 Medicare-certified hospitals with a median operating margin of -0.8%. The target's margin of 4.3% places it above the state median. Among 56 size-comparable peers (44-174 beds), the median margin is -0.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (44-174), prioritizing same-state peers. 56 hospitals in the comp set.

HospitalStateBedsRevenueMargin
VERDE VALLEY MEDICAL CENTER (Target)AZ87$172.5M4.3%
HAVASU REGIONAL MEDICAL CENTERAZ144$256.1M16.9%
SUMMIT HEALTHCAREAZ89$254.1M-2.9%
MOUNTAIN VISTA MEDICAL CENTERAZ162$223.9M-1.0%
BANNER UNIVERSITY MED CENTER SAZ132$190.9M-16.3%
HONORHEALTH SCOTTSDALE THOMPSOAZ120$187.9M-1.6%
BANNER HEART HOSPITALAZ108$162.2M17.4%
BANNER CASA GRANDE MEDICAL CENAZ141$151.2M-6.3%
NORTHWEST MEDICAL CENTER ORO VAZ96$145.8M10.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $12.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.6M+210bp18mo
Cost to Collect4.5%2.5%$3.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$3.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.1M+122bp9mo
Clean Claim Rate88.0%96.0%$110K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.6M
Cost to Collect
$3.4M
Denial Rate Reduction
$3.4M
A/R Days Reduction
$2.1M
Clean Claim Rate
$110K
Total EBITDA Uplift$12.7M
Current EBITDA$7.5M
+ RCM Uplift+$12.7M
Pro Forma EBITDA$20.2M
Current Margin4.3%
Pro Forma Margin11.7%
WC Released (1x)$6.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$11.5M$176.2M15.35x72.7%
Base (11x exit)10.0x11.0x$11.5M$197.5M17.21x76.7%
Bull Case9.0x11.0x$10.3M$243.1M23.54x88.1%
Bull (12x exit)9.0x12.0x$10.3M$268.3M25.98x91.8%
Bear Case11.0x10.0x$12.6M$109.0M8.63x53.9%
Bear (11x exit)11.0x11.0x$12.6M$123.9M9.82x57.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighElevated distress probabilityModel estimates 50.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 56 hospitals with 44-174 beds
  • Same-state prioritization (n=57)
  • Comp margins: P25=-10.9% / P50=-0.8% / P75=10.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.